Pandora Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Pandora Wealth's BMY Position: Q4 2025 in Review
Pandora Wealth reduced its Bristol-Myers Squibb (BMY) stake by 0.5% in Q4 2025, selling an estimated $4.81K and leaving 19,800 shares worth $1.07M. The position accounts for 0.65% of the portfolio, ranked #28.
Pandora Wealth first reported a position in BMY in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.21M in Q1 2025. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Pandora Wealth held 19,800 shares of Bristol-Myers Squibb worth $1.07M as of Q4 2025.
- Pandora Wealth sold 100 Bristol-Myers Squibb shares in Q4 2025, an estimated $4.81K.
- Bristol-Myers Squibb made up 0.65% of Pandora Wealth's portfolio in Q4 2025, its #28 holding.
- Pandora Wealth first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 4 quarters since.
- Pandora Wealth's Bristol-Myers Squibb position peaked at $1.21M in Q1 2025.
- 2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Pandora Wealth's 13F filing for Q4 2025, filed 4 Feb 2026.